Table 1.

Antibacterial activity in supernatants of stimulated PBMC and T/NK cells

SampleTime of stimulation (hours)Zone diameter/amount applied (mm/mg)
T/NK cells (control) 15 18.0  
T/NK cells + IL-6 15 17.1  
T/NK cells + IFN-γ 15 23.5  
T/NK cells + IL-6/IFN-γ 15 18.7  
PBMC (control) 24 22.7 
PBMC + IL-6 24 25.7  
PBMC + IFN-γ 24 29.2 
PBMC + IL-6/IFN-γ 24 21.0  
T/NK cells (control) 24 17.0  
T/NK cells + IL-6 24 17.0  
T/NK cells + IFN-γ 24 20.7  
T/NK cells + IL-6/IFN-γ 24 19.0 
SampleTime of stimulation (hours)Zone diameter/amount applied (mm/mg)
T/NK cells (control) 15 18.0  
T/NK cells + IL-6 15 17.1  
T/NK cells + IFN-γ 15 23.5  
T/NK cells + IL-6/IFN-γ 15 18.7  
PBMC (control) 24 22.7 
PBMC + IL-6 24 25.7  
PBMC + IFN-γ 24 29.2 
PBMC + IL-6/IFN-γ 24 21.0  
T/NK cells (control) 24 17.0  
T/NK cells + IL-6 24 17.0  
T/NK cells + IFN-γ 24 20.7  
T/NK cells + IL-6/IFN-γ 24 19.0 

PBMC indicates peripheral blood mononuclear cells; T/NK, T cells and natural killer cells; IL-6, interleukin-6; and IFN-γ, interferon-γ.

or Create an Account

Close Modal
Close Modal